药房工作人员对医用大麻的益处、风险和安全性的看法。

IF 2.8 3区 医学 Q2 SUBSTANCE ABUSE Substance abuse Pub Date : 2023-07-01 Epub Date: 2023-09-14 DOI:10.1177/08897077231186677
Hailey W Bulls, Andrew D Althouse, Robert Feldman, Julia H Arnsten, Jane M Liebschutz, Shannon M Nugent, Steven R Orris, Rebecca Rohac, Deepika E Slawek, Joanna L Starrels, Benjamin J Morasco, Devan Kansagara, Jessica S Merlin
{"title":"药房工作人员对医用大麻的益处、风险和安全性的看法。","authors":"Hailey W Bulls,&nbsp;Andrew D Althouse,&nbsp;Robert Feldman,&nbsp;Julia H Arnsten,&nbsp;Jane M Liebschutz,&nbsp;Shannon M Nugent,&nbsp;Steven R Orris,&nbsp;Rebecca Rohac,&nbsp;Deepika E Slawek,&nbsp;Joanna L Starrels,&nbsp;Benjamin J Morasco,&nbsp;Devan Kansagara,&nbsp;Jessica S Merlin","doi":"10.1177/08897077231186677","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Therapeutic use of cannabis is common in the United States (up to 18.7% of Americans aged ≥12), and dispensaries in the US are proliferating rapidly. However, the efficacy profile of medical cannabis is unclear, and customers often rely on dispensary staff for purchasing decisions. The objective was to describe cannabis dispensary staff perceptions of medical cannabis benefits and risks, as well as its safety in high-risk populations.</p><p><strong>Methods: </strong>Online Survey study conducted using Qualtrics from February 13, 2020 to October 2, 2020 with a national sample of dispensary staff who reportedinteracting with customers in a cannabis dispensary selling tetrahydrocannabinol-containing products. Participants were queried about benefits (\"helpfulness\") and risks (\"worry\") about cannabis for a variety of medical conditions, and safety in older adults and pregnant women on a five-point Likert scale. These results were then collapsed into three categories including \"neutral\" (3/5). \"I don't know\" (uncertainty) was a response option for helpfulness and safety.</p><p><strong>Results: </strong>Participants (n = 434) were from 29 states and included patient-facing dispensary staff (40%); managers (32%); pharmacists (13%); and physicians, nurse practitioners, or physician assistants (5%). Over 80% of participants perceived cannabis as helpful for post-traumatic stress disorder (88.7%), epilepsy (85.3%) and cancer (83.4%). Generally, participants were not concerned about potential cannabis risks, including increased use of illicit drugs (76.3%), decreases in intelligence (74.4%), disrupted sleep (71.7%), and new/worsening health problems from medical cannabis use (70.7%). Cannabis was considered safe in older adults by 81.3% of participants, though there was much less consensus on safety in pregnancy.</p><p><strong>Conclusions: </strong>Cannabis dispensary staff generally view medical cannabis as beneficial and low-risk. However, improvements in dispensary staff training, an increased role for certifying clinicians, and interventions to reduce dispensary staff concerns (e.g., cost, judgment) may improve evidence-based staff recommendations to patients seeking medical cannabis.</p>","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":" ","pages":"226-234"},"PeriodicalIF":2.8000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dispensary Staff Perceptions About the Benefits, Risks, and Safety of Cannabis for Medical Purposes.\",\"authors\":\"Hailey W Bulls,&nbsp;Andrew D Althouse,&nbsp;Robert Feldman,&nbsp;Julia H Arnsten,&nbsp;Jane M Liebschutz,&nbsp;Shannon M Nugent,&nbsp;Steven R Orris,&nbsp;Rebecca Rohac,&nbsp;Deepika E Slawek,&nbsp;Joanna L Starrels,&nbsp;Benjamin J Morasco,&nbsp;Devan Kansagara,&nbsp;Jessica S Merlin\",\"doi\":\"10.1177/08897077231186677\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Therapeutic use of cannabis is common in the United States (up to 18.7% of Americans aged ≥12), and dispensaries in the US are proliferating rapidly. However, the efficacy profile of medical cannabis is unclear, and customers often rely on dispensary staff for purchasing decisions. The objective was to describe cannabis dispensary staff perceptions of medical cannabis benefits and risks, as well as its safety in high-risk populations.</p><p><strong>Methods: </strong>Online Survey study conducted using Qualtrics from February 13, 2020 to October 2, 2020 with a national sample of dispensary staff who reportedinteracting with customers in a cannabis dispensary selling tetrahydrocannabinol-containing products. Participants were queried about benefits (\\\"helpfulness\\\") and risks (\\\"worry\\\") about cannabis for a variety of medical conditions, and safety in older adults and pregnant women on a five-point Likert scale. These results were then collapsed into three categories including \\\"neutral\\\" (3/5). \\\"I don't know\\\" (uncertainty) was a response option for helpfulness and safety.</p><p><strong>Results: </strong>Participants (n = 434) were from 29 states and included patient-facing dispensary staff (40%); managers (32%); pharmacists (13%); and physicians, nurse practitioners, or physician assistants (5%). Over 80% of participants perceived cannabis as helpful for post-traumatic stress disorder (88.7%), epilepsy (85.3%) and cancer (83.4%). Generally, participants were not concerned about potential cannabis risks, including increased use of illicit drugs (76.3%), decreases in intelligence (74.4%), disrupted sleep (71.7%), and new/worsening health problems from medical cannabis use (70.7%). Cannabis was considered safe in older adults by 81.3% of participants, though there was much less consensus on safety in pregnancy.</p><p><strong>Conclusions: </strong>Cannabis dispensary staff generally view medical cannabis as beneficial and low-risk. However, improvements in dispensary staff training, an increased role for certifying clinicians, and interventions to reduce dispensary staff concerns (e.g., cost, judgment) may improve evidence-based staff recommendations to patients seeking medical cannabis.</p>\",\"PeriodicalId\":22108,\"journal\":{\"name\":\"Substance abuse\",\"volume\":\" \",\"pages\":\"226-234\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Substance abuse\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/08897077231186677\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance abuse","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08897077231186677","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

摘要

背景:大麻的治疗性使用在美国很常见(在≥12岁的美国人中,高达18.7%),美国的药房正在迅速增加。然而,医用大麻的疗效尚不清楚,顾客通常依赖药房工作人员来做出购买决定。目的是描述大麻药房工作人员对医用大麻益处和风险的看法,以及其在高危人群中的安全性。方法:2020年2月13日至2020年10月2日,使用Qualtrics对全国药房工作人员进行的在线调查研究,这些药房工作人员报告在销售含四氢大麻酚产品的大麻药房与顾客互动。参与者被问及大麻对各种医疗条件的益处(“有益性”)和风险(“担忧”),以及对老年人和孕妇的安全性,采用Likert五点量表。这些结果随后被分解为三类,包括“中性”(3/5)。“我不知道”(不确定)是一个有用和安全的回应选项。结果:参与者(n = 434)来自29个州,包括面向患者的药房工作人员(40%);经理(32%);药剂师(13%);以及医生、执业护士或医生助理(5%)。超过80%的参与者认为大麻对创伤后应激障碍(88.7%)、癫痫(85.3%)和癌症(83.4%)有帮助。总体而言,参与者不担心潜在的大麻风险,包括非法药物使用增加(76.3%)、智力下降(74.4%)、睡眠中断(71.7%)、,以及医用大麻使用带来的新的/恶化的健康问题(70.7%)。81.3%的参与者认为大麻对老年人是安全的,尽管对怀孕安全性的共识要少得多。结论:大麻药房工作人员普遍认为医用大麻有益且风险低。然而,药房工作人员培训的改进、临床医生认证作用的增强以及减少药房工作人员担忧的干预措施(如成本、判断)可能会改善循证工作人员对寻求医用大麻的患者的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Dispensary Staff Perceptions About the Benefits, Risks, and Safety of Cannabis for Medical Purposes.

Background: Therapeutic use of cannabis is common in the United States (up to 18.7% of Americans aged ≥12), and dispensaries in the US are proliferating rapidly. However, the efficacy profile of medical cannabis is unclear, and customers often rely on dispensary staff for purchasing decisions. The objective was to describe cannabis dispensary staff perceptions of medical cannabis benefits and risks, as well as its safety in high-risk populations.

Methods: Online Survey study conducted using Qualtrics from February 13, 2020 to October 2, 2020 with a national sample of dispensary staff who reportedinteracting with customers in a cannabis dispensary selling tetrahydrocannabinol-containing products. Participants were queried about benefits ("helpfulness") and risks ("worry") about cannabis for a variety of medical conditions, and safety in older adults and pregnant women on a five-point Likert scale. These results were then collapsed into three categories including "neutral" (3/5). "I don't know" (uncertainty) was a response option for helpfulness and safety.

Results: Participants (n = 434) were from 29 states and included patient-facing dispensary staff (40%); managers (32%); pharmacists (13%); and physicians, nurse practitioners, or physician assistants (5%). Over 80% of participants perceived cannabis as helpful for post-traumatic stress disorder (88.7%), epilepsy (85.3%) and cancer (83.4%). Generally, participants were not concerned about potential cannabis risks, including increased use of illicit drugs (76.3%), decreases in intelligence (74.4%), disrupted sleep (71.7%), and new/worsening health problems from medical cannabis use (70.7%). Cannabis was considered safe in older adults by 81.3% of participants, though there was much less consensus on safety in pregnancy.

Conclusions: Cannabis dispensary staff generally view medical cannabis as beneficial and low-risk. However, improvements in dispensary staff training, an increased role for certifying clinicians, and interventions to reduce dispensary staff concerns (e.g., cost, judgment) may improve evidence-based staff recommendations to patients seeking medical cannabis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Substance abuse
Substance abuse SUBSTANCE ABUSE-
CiteScore
5.90
自引率
2.90%
发文量
88
审稿时长
>12 weeks
期刊介绍: Now in its 4th decade of publication, Substance Abuse journal is a peer-reviewed journal that serves as the official publication of Association for Medical Education and Research in Substance Abuse (AMERSA) in association with The International Society of Addiction Medicine (ISAM) and the International Coalition for Addiction Studies in Education (INCASE). Substance Abuse journal offers wide-ranging coverage for healthcare professionals, addiction specialists and others engaged in research, education, clinical care, and service delivery and evaluation. It features articles on a variety of topics, including: Interdisciplinary addiction research, education, and treatment Clinical trial, epidemiology, health services, and translation addiction research Implementation science related to addiction Innovations and subsequent outcomes in addiction education Addiction policy and opinion International addiction topics Clinical care regarding addictions.
期刊最新文献
Cocaine Use is Associated With Increased LVMI in Unstably Housed Women With Polysubstance Use. Impact of Mandated Case Review Policy on Opioid Discontinuation and Mortality Among High-Risk Long-Term Opioid Therapy Patients: The STORM Stepped-Wedge Cluster Randomized Controlled Trial. Improving DEIB in Addiction Medicine Training Through Interdisciplinary Collaboration and Program Evaluation. Advancing Proficiencies for Health Professionals in the Treatment of Tobacco Use Among Marginalized Communities: Development of a Competency-Based Curriculum and Virtual Workshop. Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1